Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.98
0.03 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.97
-0.34%
After-hours: Aug 15, 2025, 05:01 PM EDT

Compass Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a 850K n/a 2.84M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
367K n/a n/a n/a n/a 463K 468K 466K 475K 481K 484K 487K 498K 435K 396K 406K 409K 413K
Gross Profit
-367K n/a n/a n/a 850K -463K 2.38M -466K -475K -481K -484K -487K -498K -435K -396K -406K -409K -413K
Operating Income
-21.07M -17.97M -16.57M -12.24M -15.04M -12.77M -15.39M -11.93M -13.34M -9.71M -12.89M -12.6M -8.99M -7.18M -13M -5.85M -55.69M -7.34M
Interest Income
1.19M n/a 1.59M 1.76M 1.97M n/a 1.98M 1.96M 2.06M n/a 1.29M 623K 424K 20K 4K 1K 9K 15K
Pretax Income
-19.88M -16.63M -15.03M -10.48M -13.08M -10.79M -13.41M -9.96M -11.28M -7.84M -11.59M -11.97M -8.49M -7.16M -12.99M -5.97M -55.79M -7.42M
Net Income
-19.88M -16.63M -15.03M -10.48M -13.08M -10.79M -13.41M -9.96M -11.28M -5.96M -10.3M -11.35M -8M -7.14M -12.98M -5.97M -55.8M -7.42M
Selling & General & Admin
4.65M 4.91M 3.54M 3.63M 4.72M 2.94M 2.66M 3.1M 3.11M 3.07M 2.96M 2.81M 3.13M 2.77M 3.43M 2.7M 2.17M 2.63M
Research & Development
16.41M 13.05M 13.04M 8.61M 11.17M 9.37M 12.27M 8.83M 10.22M 6.64M 9.93M 9.79M 5.86M 4.42M 9.57M 3.15M 2.9M 4.7M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.87M n/a n/a n/a n/a 50.62M -44K 50.62M n/a
Operating Expenses
21.07M 17.97M 16.57M 12.24M 15.89M 12.31M 14.93M 11.93M 13.34M 9.71M 12.89M 12.6M 8.99M 7.18M 13M 5.85M 5.07M 7.34M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.29M 623K 424K 20K 39K 78K 111K 142K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -309K -307K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.07M 17.97M 16.57M 12.24M 15.89M 12.77M 15.39M 11.93M 13.34M 9.71M 12.89M 12.6M 8.99M 7.18M 13M 5.85M 5.07M 7.34M
Income Tax Expense
n/a n/a n/a n/a n/a 419.72K 1.87M 505.59K 352.92K -1.87M -1.29M -623K -493K -20K -13K 34K 13K 142K
Shares Outstanding (Basic)
138.28M 138.24M 136.63M 137.59M 137.59M 136.61M 127.67M 127.42M 126.73M 126.38M 105.19M 101.01M 100.95M 100.86M 51.91M 61.69M 51.91M 51.31M
Shares Outstanding (Diluted)
138.28M 138.24M 136.63M 137.59M 137.59M 136.61M 127.67M 127.42M 126.73M 126.38M 105.19M 101.01M 100.95M 100.86M 51.91M 61.69M 51.91M 51.31M
EPS (Basic)
-0.14 -0.12 -0.11 -0.08 -0.1 -0.08 -0.11 -0.08 -0.09 -0.05 -0.1 -0.11 -0.08 -0.07 -0.25 -0.1 -1.07 -0.14
EPS (Diluted)
-0.14 -0.12 -0.11 -0.08 -0.1 -0.08 -0.11 -0.08 -0.09 -0.05 -0.1 -0.11 -0.08 -0.07 -0.25 -0.1 -1.07 -0.14
EBITDA
-21.07M -17.6M -16.21M -11.77M -14.58M -12.31M -14.93M -11.46M -12.86M -9.23M -11.11M -11.49M -8.06M -6.73M -12.6M -5.49M -4.65M -6.91M
EBIT
-19.88M -17.97M -16.57M -12.24M -15.04M -12.77M -15.39M -11.93M -13.34M -9.71M n/a n/a n/a -7.18M -13M -5.85M n/a -7.34M
Depreciation & Amortization
n/a 364K 359K 465K 466K 463K 468K 466K 475K 481K 484K 487K 498K 435K 396K 406K 409K 413K